benoxathian has been researched along with rx 821002 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Starke, K; Trendelenburg, AU; Wahl, CA | 1 |
Erami, C; Faber, JE; French, DM; Ho, JG; Zhang, H | 1 |
2 other study(ies) available for benoxathian and rx 821002
Article | Year |
---|---|
Antagonists that differentiate between alpha 2A-and alpha 2D-adrenoceptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Autoreceptors; Benzofurans; Brimonidine Tartrate; Cerebral Cortex; Dioxanes; Electric Stimulation; Female; Guinea Pigs; Idazoxan; Imidazoles; Isotope Labeling; Male; Norepinephrine; Oxathiins; Quinolizines; Quinoxalines; Rabbits; Receptors, Adrenergic, alpha-2; Structure-Activity Relationship; Tritium | 1996 |
Alpha(1)-adrenoceptor stimulation directly induces growth of vascular wall in vivo.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angioplasty, Balloon; Animals; Carotid Artery Injuries; Cell Division; Idazoxan; Imines; Indoles; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxathiins; Piperazines; Piperidines; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Recurrence; Tunica Intima; Vasoconstrictor Agents | 2002 |